Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids. | Int J Mol Sci | 2021 | 33805378 | PubTator, text mining | PubMed |
| Recent Advances in Oligonucleotide Therapeutics in Oncology. | Int J Mol Sci | 2021 | 33804856 | PubTator, text mining | PubMed |
| Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers? | Brain Sci | 2021 | 33801069 | PubTator, text mining | PubMed |
| A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check. | Int J Neonatal Screen | 2021 | 33801060 | PubTator, text mining | PubMed |
| Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications. | Cancers (Basel) | 2021 | 33800703 | PubTator, text mining | PubMed |
| Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments. | Cells | 2021 | 33800164 | PubTator, text mining | PubMed |
Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants. | J Mol Diagn | 2021 | 33798739 | PubTator, text mining | PubMed |
| Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit. | Nat Neurosci | 2021 | 33795885 | PubTator, text mining | PubMed |
| Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment. | Ann Clin Transl Neurol | 2021 | 33792208 | PubTator, text mining | PubMed |
| Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy. | Clin Pharmacol Ther | 2021 | 33792051 | PubTator, text mining | PubMed |
| Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years. | Orphanet J Rare Dis | 2021 | 33789695 | PubTator, text mining | PubMed |
| Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy. | Ann Clin Transl Neurol | 2021 | 33788421 | PubTator, text mining | PubMed |
| Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy. | Front Genet | 2021 | 33777091 | PubTator, text mining | PubMed |
| Severe cervical compressive polydiscopathic myelopathy with features of motor neuron disease: A case report. | Clin Case Rep | 2021 | 33768823 | PubTator, text mining | PubMed |
| Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec. | Mol Ther Methods Clin Dev | 2021 | 33768131 | PubTator, text mining | PubMed |
| Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy. | Orphanet J Rare Dis | 2021 | 33761963 | PubTator, text mining | PubMed |
| Reduced network integration in default mode and executive networks is associated with social and personal optimism biases. | Hum Brain Mapp | 2021 | 33755272 | PubTator, text mining | PubMed |
| Identification and structural analysis of the Schizosaccharomyces pombe SMN complex. | Nucleic Acids Res | 2021 | 33754639 | Swiss-Prot, curated | PubMed |
| [Prenatal diagnosis of spinal muscular atrophy using multiple ligation-dependent probe amplification]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2021 | 33751527 | PubTator, text mining | PubMed |
| Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities. | Expert Opin Investig Drugs | 2021 | 33749510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=67